Listed companies are obliged by law to publish without delay news of all company occurrences that could influence the share price significantly (Article 17 of the European Market Abuse Regulation (MAR)). We are committed to transparency and want to ensure that all capital market participants have access to key information about our company as quickly as possible, and thus prevent insider dealing due to any information asymmetry.
Our investor base is as diverse and international as our company itself. Since our share is a bearer share only, NASDAQ provides an analysis of our top investors as well as our shareholder structure by type and region.
Directors' DealingsRead More
As required by German law, we are transparent about any transactions, above a certain threshold, made by persons discharging managerial responsibilities at Merck KGaA, Darmstadt, Germany.
Voting Rights NotificationsRead More
Voting Rights Notifications
Investors are required by law to inform Merck KGaA, Darmstadt, Germany, and the responsible German Authorities if certain thresholds concerning their Voting Rights are reached or crossed.
Related NewsView All News
Merck KGaA, Darmstadt, Germany, today announced the latest research representing the Company’s innovative oncology portfolio has been accepted for presentation at this year’s ASCO.